Application of Hydroxyethyl Starch 200/0.5 Injection for Acute Ischemic Stroke and Evidencebased Medical Evaluation

GAO Bei,LIU Fang

DOI: https://doi.org/10.14009/j.issn.1672-2124.2012.09.012

2012-01-01

Abstract:OBJECTIVE: To investigate the application of hydroxyethyl NaCl injection(hydroxyethyl starch 200/0.5 injection for short) for acute ischemic stroke,and to perform an evidence-based medical evaluation so as to provide reference for rational use of hydroxyethyl starch 200/0.5 injection.METHODS: We collected the medical records of the patients with acute ischemic stroke in the department of nephrology of our hospital who were treated with hydroxyethyl starch 200/0.5 from June 2010 to October 2010.The indication,usage and dosage,medication time,course of treatment and safety of hydroxyethyl starch 200/0.5 were investigated,and the use of hydroxyethyl starch 200/0.5 injection was evaluated in accordance with drug package insert,treatment guidelines and clinical research evidence.RESULTS: A total of 86 cases were included.The treatment was in line with the related guidelines in 5.8%(5/86) cases in which hydroxyethyl starch 200/0.5 was used for cerebral watershed infarction.Evidence of class 2b level was noted in 5.8%(5/86) cases in which hydroxyethyl starch 200/0.5 was used for multiple-cerebral infarction,evidence of class 1a level in 55.8%(48/86) cases in which hydroxyethyl starch 200/0.5 was used for middle cerebral artery occlusion,and evidence of class 4 level in 2.3%(2/86) cases in which hydroxyethyl starch 200/0.5 was used for carotid artery occlusion.30.2%(26/86) used hydroxyethyl starch 200/0.5 in the absence of clinical research evidence-based indications.Hydroxyethyl starch 200/0.5 was used for an average of(13.66±5.81) days,and 65(75.6%) used hydroxyethyl starch 200/0.5 for a duration longer than 10 days as labeled in package inserts.The single dose for all cases was 500 mL at an infusion rate of 160-200 mL·h-1 that was faster than the infusion rate as described by the package inserts.CONCLUSION: In some acute ischemic stroke cases,the hydroxyethyl starch 200/0.5 was used in the absence of clinical research evidence and the usage and course of treatment were not in line with those labeled in package inserts.